Literature for phosphoramidon (M04.001 inhibitor)

Summary Structure Literature

(Topics flags: A Assay, S Structure, I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

    2019
  1. Baulig,A., Helmle,I., Bader,M., Wolf,F., Kulik,A., Al-Dilaimi,A., Wibberg,D., Kalinowski,J., Gross,H. and Kaysser,L.<br>Biosynthetic reconstitution of deoxysugar phosphoramidate metalloprotease inhibitors using an N-P-bond-forming kinase<br>Chem Sci (2019) 10, 4486-4490. PubMed  Europe PubMed DOI  PMC  EPMC  I
  2. Labiuk,S.L., Sygusch,J. and Grochulski,P.<br>Structures of soluble rabbit neprilysin complexed with phosphoramidon or thiorphan<br>Acta Crystallogr F Struct Biol Commun (2019) 75, 405-411. PubMed  Europe PubMed DOI  S  I
  3. Lymperis,E., Kaloudi,A., Kanellopoulos,P., de Jong,M., Krenning,E.P., Nock,B.A. and Maina,T.<br>Comparing Gly(11)/dAla(11)-replacement vs. the in-situ neprilysin-inhibition approach on the tumor-targeting efficacy of the (111)In-SB3/(111)In-SB4 radiotracer pair<br>Molecules (2019) 24 PubMed  Europe PubMed DOI  I
  4. Lymperis,E., Kaloudi,A., Kanellopoulos,P., Krenning,E.P., de Jong,M., Maina,T. and Nock,B.A.<br>Comparative evaluation of the new GRPR-antagonist (111) In-SB9 and (111) In-AMBA in prostate cancer models: implications of in vivo stability<br>J Labelled Comp Radiopharm (2019) 62, 646-655. PubMed  Europe PubMed DOI  I
  5. 2017
  6. Bivehed,E., Stromvall,R., Bergquist,J., Bakalkin,G. and Andersson,M.<br>Region-specific bioconversion of dynorphin neuropeptide detected by in situ histochemistry and MALDI imaging mass spectrometry<br>Peptides (2017) 87, 20-27. PubMed  Europe PubMed DOI  I
  7. 2016
  8. Kaloudi,A., Nock,B.A., Lymperis,E., Krenning,E.P., de Jong,M. and Maina,T.<br>Improving the in vivo profile of minigastrin radiotracers: a comparative study involving the neutral endopeptidase inhibitor phosphoramidon<br>Cancer Biother Radiopharm (2016) 31, 20-28. PubMed  Europe PubMed DOI  I
  9. 2013
  10. Dos Santos,M.H., da Costa,A.F., Ferreira,B.J., Souza,S.L., da Silva Lannes,P., Santos,G.S., Mattos-Guaraldi,A.L. and Nagao,P.E.<br>A phosphoramidon-sensitive metalloprotease induces apoptosis of human endothelial cells by Group B Streptococcus<br>Antonie Van Leeuwenhoek (2013) 104, 1125-1133. PubMed  Europe PubMed DOI  I
  11. Morisaki,N., Ohuchi,A. and Moriwaki,S.<br>The role of neprilysin in regulating the hair cycle<br>PLoS ONE (2013) 8, e55947-e55947. PubMed  Europe PubMed DOI  PMC  EPMC  I
  12. 2011
  13. Ferraris,D.M., Sbardella,D., Petrera,A., Marini,S., Amstutz,B., Coletta,M., Sander,P. and Rizzi,M.<br>Crystal structure of Mycobacterium tuberculosis zinc-dependent metalloprotease-1 (Zmp1), a metalloprotease involved in pathogenicity<br>J Biol Chem (2011) 286, 32475-32482. PubMed  Europe PubMed DOI  S  I
  14. 2010
  15. Marr,R.A. and Spencer,B.J.<br>NEP-like endopeptidases and Alzheimer's disease [corrected]<br>Curr Alzheimer Res (2010) 7, 223-229. PubMed  Europe PubMed DOI  I
  16. 2009
  17. Schulz,H., Dale,G.E., Karimi-Nejad,Y. and Oefner,C.<br>Structure of human endothelin-converting enzyme I complexed with phosphoramidon<br>J Mol Biol (2009) 385, 178-187. PubMed  Europe PubMed DOI  S  I
  18. 2008
  19. Bhavsar,T.M., Cerreta,J.M., Liu,M., Reznik,S.E. and Cantor,J.O.<br>Phosphoramidon, an endothelin-converting enzyme inhibitor, attenuates lipopolysaccharide-induced acute lung injury<br>Exp Lung Res (2008) 34, 141-154. PubMed  Europe PubMed DOI  I
  20. 2001
  21. Bur,D., Dale,G.E. and Oefner,C.<br>A three-dimensional model of endothelin-converting enzyme (ECE) based on the X-ray structure of neutral endopeptidase 24.11 (NEP)<br>Protein Eng (2001) 14, 337-341. PubMed  Europe PubMed  S  I
  22. 2000
  23. [YEAR:18-2-2000]Oefner,C., D'arcy,A., Hennig,M., Winkler,F.K. and Dale,G.E.<br>Structure of human neutral endopeptidase (neprilysin) complexed with phosphoramidon<br>J Mol Biol (18-2-2000) 296, 341-349. PubMed  Europe PubMed DOI  S  I
  24. 1997
  25. Louis,D., Kohlmann,M. and Wallach,J.<br>Spectrophotometric assay for amidolytic activity of alkaline protease from Pseudomonas aeruginosa<br>Anal Chim Acta (1997) 345, 219-225.  A  I
  26. 1995
  27. Balwierczak,J.L., Kukkola,P.J., Savage,P. and Jeng,A.Y.<br>Effects of metalloprotease inhibitors on smooth muscle endothelin-converting enzyme activity<br>Biochem Pharmacol (1995) 49, 291-296. PubMed  Europe PubMed DOI  I
  28. de Nanteuil,G., Benoist,A., Remond,G., Descombes,J.J., Barou,V. and Verbeuren,T.J.<br>Synthesis of the endothelin converting enzyme inhibitor phosphoramidon<br>Tetrahedron Lett (1995) 36, 1435-1438.  I
  29. Emoto,N. and Yanagisawa,M.<br>Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum<br>J Biol Chem (1995) 270, 15262-15268. PubMed  Europe PubMed DOI  I
  30. Kukkola,P.J., Savage,P., Sakane,Y., Berry,J.C., Bilci,N.A., Ghai,R.D. and Jeng,A.Y.<br>Differential structure-activity relationships of phosphoramidon analogues for inhibition of three metalloproteases: endothelin-converting enzyme, neutral endopeptidase, and angiotensin- converting enzyme<br>J Cardiovasc Pharmacol (1995) 26 Suppl 3, S65-S68. PubMed  Europe PubMed  I
  31. 1994
  32. Schmidt,M., Kroger,B., Jacob,E., Seulberger,H., Subkowski,T., Otter,R., Meyer,T., Schmalzing,G. and Hillen,H.<br>Molecular characterization of human and bovine endothelin converting enzyme (ECE-1)<br>FEBS Lett (1994) 356, 238-243. PubMed  Europe PubMed DOI  I
  33. 1992
  34. Pollock,D.M., Shiosaki,K., Sullivan,G.M. and Opgenorth,T.J.<br>Rhamnose moiety of phosphoramidon is not required for in vivo inhibition of endothelin converting enzyme<br>Biochem Biophys Res Commun (1992) 186, 1146-1150. PubMed  Europe PubMed DOI  I
  35. 1986
  36. Kitagishi,K. and Hiromi,K.<br>Binding between thermolysin and its specific inhibitor, N-phosphoryl-L-leucyl-L-tryptophan (PLT)<br>J Biochem (1986) 99, 191-197. PubMed  Europe PubMed  I
  37. [YEAR:2-6-1986]Tronrud,D.E., Monzingo,A.F. and Matthews,B.W.<br>Crystallographic structural analysis of phosphoramidates as inhibitors and transition-state analogs of thermolysin<br>Eur J Biochem (2-6-1986) 157, 261-268. PubMed  Europe PubMed  S  I
  38. 1984
  39. Kitagishi,K. and Hiromi,K.<br>Binding between thermolysin and its specific inhibitor, phosphoramidon<br>J Biochem (1984) 95, 529-534. PubMed  Europe PubMed  I
  40. [YEAR:15-10-1984]Matsas,R., Kenny,A.J. and Turner,A.J.<br>The metabolism of neuropeptides. The hydrolysis of peptides, including enkephalins, tachykinins and their analogues, by endopeptidase-24.11<br>Biochem J (15-10-1984) 223, 433-440. PubMed  Europe PubMed  PMC  EPMC  I
  41. [YEAR:5-6-1984]Poncz,L., Gerken,T.A., Dearborn,D.G., Grobelny,D. and Galardy,R.E.<br>Inhibition of the elastase of Pseudomonas aeruginosa by N alpha-phosphoryl dipeptides and kinetics of spontaneous hydrolysis of the inhibitors<br>Biochemistry (5-6-1984) 23, 2766-2772. PubMed  Europe PubMed  I
  42. 1982
  43. Fulcher,I.S., Matsas,R., Turner,A.J. and Kenny,A.J.<br>Kidney neutral endopeptidase and the hydrolysis of enkephalin by synaptic membranes show similar sensitivity to inhibitors<br>Biochem J (1982) 203, 519-522. PubMed  Europe PubMed  PMC  EPMC  I
  44. 1978
  45. Morihara,K. and Tsuzuki,H.<br>Phosphoramidon as an inhibitor of elastase from Pseudomonas aeruginosa<br>Jpn J Exp Med (1978) 48, 81-84. PubMed  Europe PubMed  I
  46. 1977
  47. Weaver,L.H., Kester,W.R. and Matthews,B.W.<br>A crystallographic study of the complex of phosphoramidon with thermolysin. A model for the presumed catalytic transition state and for the binding of extended substrates<br>J Mol Biol (1977) 114, 119-132. PubMed  Europe PubMed  S  I
  48. 1973
  49. Suda,H., Aoyagi,T., Takeuchi,T. and Umezawa,H.<br>A thermolysin inhibitor produced by actinomycetes: phosphoramidon<br>J Antibiot (Tokyo) (1973) 26, 621-623. PubMed  Europe PubMed  I